FDA Panel Rejects Avastin as Breast Cancer Drug
07/20/2010
A Food and Drug Administration panel gave a negative recommendation for Roche Holding AG cancer drug, Avastin (Bevacizumab), the leading company´s product will no longer be prescribed as breast cancer treatment. The 12 to 1 votation ended Avastin as an option for breast cancer drug.
2008 and 2009 Comparative Chart
QTR, Actelion Ltd., 1Semester 2010 Best Selling Drugs
07/20/2010
Actelion Ltd. presented 1 Semester 2010 Best Selling Drugs, with Tracleer(Bosentan)to treat Pulmonary Arterial Hypertension, followed by Ventavis(Iloprost) also to treat Pulmonary Arterial Hypertension and also followed by Zavesca(Miglustat) to treat Niemann-Pick type C.
Mylan Inc. Cleared by FDA for Boehringer Ingelheim Generic Drug to Treat High Blood Pressure
07/20/2010
Mylan Inc. announced that the Food and Drug Administration cleared generic version of Boehringer Ingelheim GmbH drug, Catapres-TTS, indicated to treat high-blood pressure.
2008 and 2009 Comparative Chart
QTR,Johnson & Johnson Inc, 2010 1 Semester, Best Selling Drugs
07/20/2010
QTR, Johnson & Johnson Inc. presented 1 Semester Best Selling Drugs, with Remicade(Infliximab)Rheumatoid Arthritis, and Eprex/Procrit(Epoetin Alfa) to treat EPO/Anemia, with Risperdal Consta(RisperidoneAtypical) Antypshychotic.
2008 and 2009 Comparative Chart
QTR, Forest Labs, 1Q 2010 Best Selling Drugs
07/20/2010
Forest Labs presented 1Q 2010 best selling drugs, with Lexapro (Escitalopra) MajorDepressiveDisorder/Generalized Anxiety Disorder, followed by Namenda(Memantine) to treat Alzheimer and Bystolic(Nebivolol) Antihypertensive.
2008 and 2009 Comparative Chart
QTR, Novartis, 2Q 2010 Best Selling Drugs
07/20/2010
Novartis AG presented 2Q 2010 best selling drugs, with Diovan( Valsartan) Antihypertensive, followed by Gleevec/Glivec (Imatinib) to treat Chronic Myeloid Leukemia and Zometa (Zoledronic Acid) to treat Complications of Cancer.
Sanofi Aventis: NICE Reconmends Use of Multaq in Patients with Atrial Fibrillation.
07/20/2010
The National Institute for Health and Clinical Excellence (NICE) British Watchdog, recommended use of Sanofi-Aventis drug, Multaq (Donedarone) indicated for patients with atrial fibrillation and to be reimbursed by the National Health Service.
Amyotrophic lateral sclerosis
Amorfix Life Sciences grants Biogen Idec global rights for amyotrophic lateral sclerosis drug.
07/20/2010
Amorfix Life Sciences Inc. granted global rights for Biogen Idec Inc to market monoclonal antibodies to treat patients suffering from amyotrophic lateral sclerosis (ALS).
Mylan Inc. Cleared by FDA for Boehringer Ingelheim Generic Drug to Treat High Blood Pressure
07/20/2010
Mylan Inc. announced that the Food and Drug Administration cleared generic version of Boehringer Ingelheim GmbH drug, Catapres-TTS, indicated to treat high-blood pressure.
- BLOG
- VIDEOS
- NM Extra
Perrigo Challenges GSK Dermathosis Drug Patent
07/19/2010
Perrigo & Co. submited an Abbreviated New Drug Applicaton of Olux-E Foam Drug, indicated to treat moderate to severe dermathosis.
Unanimously
FDA Panel Recommends Use of Avandia but Warns about Heart Risks
07/19/2010
Over a total of 32 experts, 17 belong to the Food and Drug Administration advisory panel, recommended use of GlaxoSmithKline Plc. Avandia (Rosiglitazone) drug, indicated to treat diabetes type 2.
Multiple Sclerosis: Study says that neurologists have litle knowledge of Novartis oral drug compared to Merck KGaA
07/19/2010
Decision Resources, finds that surveyed neurologists have low awareness of Novartis-Mitsubishi Tanabes, Gilenia (Fingolimod), among the surveyed oral emerging therapies for the treatment of multiple sclerosis (MS).
